| Bioactivity | RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis. | ||||||
| Invitro | RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus. RNAIII-inhibiting peptide (RIP) inhibits the synthesis of both RNAII and RNAIII, while RAP activates in wild type S. aureus cells. RNAIII-inhibiting peptide (5 μg/106 cells) potently reduces bacterial cell adhesion to HEp2 cells in the absence of serum, but with slight overall reduction the presence of serum. RNAIII-inhibiting peptide inhibits while RAP induces the phosphorylation of TRAP[1]. | ||||||
| Name | RNAIII-inhibiting peptide(TFA) | ||||||
| Sequence | Tyr-Ser-Pro-Trp-Thr-Asn-Phe | ||||||
| Shortening | YSPWTNF | ||||||
| Formula | C47H57F3N10O13 | ||||||
| Molar Mass | 1027.01 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
RNAIII-inhibiting peptide(TFA)
CAS: F: C47H57F3N10O13 W: 1027.01
RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus, effective in the diseases such as celluli
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.